Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications
Sarah E. Kelly, Altomare Di Benedetto, Adelaide Greco et al. · 2010
Read Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications by Sarah E. Kelly, Altomare Di Benedetto, Adelaide Greco et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010035.txt.
Description
Sarah E Kelly leads a 2010 PLOS ONE study on growing cancer stem cells, a small tumor subset blamed for starting and keeping cancer going. A surface marker called CD133 flags such cells. They usually resist chemotherapy, the drug treatment for cancer.
Cells from several cancer lines grew in a NASA-built spinning vessel that mimics low gravity. After seven days, the CD133 cell share rose about fifteen-fold there, while a rival vessel cut it. Surprisingly, the grown stem-like cells became sensitive to common cancer drugs instead of resistant. If lab drug tests can include these cells, doctors may tailor drug plans to patients more closely, the authors suggest.
Catalog record
| CREATOR | Sarah E. Kelly, Altomare Di Benedetto, Adelaide Greco et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010035